Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HiCM-188 in Congestive Heart Failure
NCT04982081Phase 1Unknown
- Sponsor
- Help Therapeutics
- Start
- Sep 2021
- Primary completion
- Dec 2022
- Modality
- Patient-derived iPSCs, Allogeneic iPSCs
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of HiCM-188 in heart failure (HF) (2 arms), sponsored by Help Therapeutics. Primary endpoint: Incidence of major serious adverse events at 1 month. Status: unknown.
02
Drugs
HiCM-188
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT04982081.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04982081.